Along with extensive experience and scientific expertise, Charles River provides a strategic and consultative-based approach to conducting studies for cellular therapeutics. With focused attention to safety and, as applicable, efficacy aspects, each cellular therapeutic program integrates the most comprehensive scientific and regulatory approaches developed by our multidisciplinary team. The goal of all of our cellular therapy programs is to clearly define any safety issues and, when necessary, place into perspective any risk factors inherent in a cellular therapy product.

You may also be interested in...

5 Tips for Preclinical Assessment of Cell Therapies

Comprehensive preclinical assessment of stem cell therapies is critical for regulatory approval and to ensure safety in first-in-human clinical trials. Here are some tips for a successful translational cell therapy program.